World's Best Scientists 2026 revealed!
Amyotrophic Lateral Sclerosis
H-index 25

Amyotrophic Lateral Sclerosis

1748-2968

Published by: Taylor & Francis

https://www.tandfonline.com/toc/iafd19/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 953 99 202 24

Additional Metrics

Number of Best Scientists*: 194
Documents by Best Scientists*: 275
Top 100 Ranked Scientists*: 8
SCIMAGO H-index:
SCIMAGO SJR:
Impact Factor: N/A

Overview

Top Research Topics at Amyotrophic Lateral Sclerosis?

Amyotrophic Lateral Sclerosis tackles a plethora of topics, such as Amyotrophic lateral sclerosis, Internal medicine, Disease, Neuroscience and Pathology. Genetics, Physical medicine and rehabilitation, Motor neuron, Physical therapy and Pediatrics are some topics wherein Amyotrophic lateral sclerosis research discussed in Amyotrophic Lateral Sclerosis have an impact. Amyotrophic Lateral Sclerosis primarily discusses Genetics topics, particularly Gene, SOD1, Mutation, Phenotype and Exon.

Pediatrics research presented in Amyotrophic Lateral Sclerosis encompasses a variety of subjects, including Epidemiology and Incidence (epidemiology). It holds forums on Internal medicine that merges themes from other disciplines such as Endocrinology, Surgery, Oncology and Cardiology.

  • Amyotrophic lateral sclerosis (85.50%)
  • Internal medicine (19.03%)
  • Disease (16.09%)

What are the most cited papers published in the journal?

  • El Escorial revisited : revised criteria for the diagnosis of amyotrophic lateral sclerosis (3587 citations)
  • Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) (664 citations)
  • Prognostic factors in ALS: A critical review (617 citations)

Research areas of the most cited articles at Amyotrophic Lateral Sclerosis:

The journal publications aim to foster the development of research in Amyotrophic lateral sclerosis, Internal medicine, Physical therapy, Neuroscience and Disease. Research in the field of Pathology was used to conduct the presented Amyotrophic lateral sclerosis studies in the journal papers. Issues in Internal medicine were discussed in the published articles, taking into consideration concepts from other disciplines like Gastroenterology and Oncology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Disease
  • Gene

The previous edition focused in particular on these issues:

Amyotrophic lateral sclerosis, Internal medicine, Disease, Clinical trial and Pediatrics are the subjects of interest in Amyotrophic Lateral Sclerosis. It tackles research in various disciplines, including Amyotrophic lateral sclerosis and In patient. In addition to Internal medicine research, Amyotrophic Lateral Sclerosis aims to explore topics under Gastroenterology, Oncology and Cardiology.

Amyotrophic Lateral Sclerosis is mostly focused on Disease, specifically Motor neuron. The research on Epidemiology featured in it combines topics in other fields like Demography and Incidence (epidemiology). The concepts on Proportional hazards model presented in Amyotrophic Lateral Sclerosis can also apply to other research fields, including Cohort and Hazard ratio.

The most cited articles from the last journal are:

  • Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016 (38 citations)
  • Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. (10 citations)
  • The human gut microbiota in people with amyotrophic lateral sclerosis. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Amyotrophic Lateral Sclerosis (based on the number of publications) are:

  • Orla Hardiman (84 papers) published 5 papers at the last edition, 3 less than at the previous edition,
  • Mamede de Carvalho (66 papers) published 6 papers at the last edition, 3 more than at the previous edition,
  • Adriano Chiò (65 papers) published 10 papers at the last edition, 5 more than at the previous edition,
  • Leonard H. van den Berg (60 papers) published 6 papers at the last edition, 1 less than at the previous edition,
  • Ammar Al-Chalabi (59 papers) published 2 papers at the last edition, 3 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Amyotrophic Lateral Sclerosis (based on the number of publications) are:

  • Harvard University (101 papers) published 9 papers at the last edition, 1 less than at the previous edition,
  • King's College London (82 papers) published 4 papers at the last edition, 1 less than at the previous edition,
  • University of Sheffield (69 papers) published 8 papers at the last edition, 1 more than at the previous edition,
  • University of Turin (65 papers) published 10 papers at the last edition, 5 more than at the previous edition,
  • Trinity College, Dublin (56 papers) published 4 papers at the last edition, 4 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 3.85% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 30.40% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.60% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 28.00% of all publications and 32.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Exploring Career Scope and Future Studies in Amyotrophic Lateral Sclerosis Research

After understanding the depth and complexity of Amyotrophic Lateral Sclerosis research, it's equally important to explore career prospects and further studies. For individuals interested in continuing their study and research into Amyotrophic Lateral Sclerosis, clinical roles such as nurse practitioners often play a crucial part in care management, disease education, and ongoing research. Specifically, the state of Minnesota has some of the leading programs for those interested in pursuing their nurse practitioner degrees as well as specialization in neurological disorders like Amyotrophic Lateral Sclerosis. These programs integrate academics, practical experience, and in-depth research opportunities to equip students with the necessary competence to contribute significantly to this field. Nurse practitioners specialized in neurological diseases often work in tandem with neurologists, contributing to diagnostics, patient care, and symptomatic management. They also become key players in research studies, improving our overall understanding of conditions like Amyotrophic Lateral Sclerosis. For more information regarding these specialized courses, we recommend checking out these top-notch nurse practitioner programs in Minnesota and taking a step towards making impactful contributions to Amyotrophic Lateral Sclerosis research.

Top Publications

  • Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

    Jesus S. Mora;Angela Genge;Adriano Chio;Conrado J. Estol

    (2020)
    184 Citations
  • The human gut microbiota in people with amyotrophic lateral sclerosis.

    Katharine Nicholson;Kjetil Bjornevik;Galeb Abu-Ali;Galeb Abu-Ali;James Chan

    (2021)
    76 Citations
  • The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review

    Jochem Helleman;Esther T. Kruitwagen;Leonard H. van den Berg;Johanna M. A. Visser-Meily

    (2020)
    69 Citations
  • Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study.

    Enrica Bersano;Maria Francesca Sarnelli;Valentina Solara;Barbara Iazzolino

    (2020)
    56 Citations
  • A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS.

    Jeremy M. Shefner;Jinsy A. Andrews;Angela Genge;Carlayne Jackson

    (2021)
    49 Citations
  • Focus on the heterogeneity of amyotrophic lateral sclerosis

    Caterina Bendotti;Valentina Bonetto;Elisabetta Pupillo;Giancarlo Logroscino

    (2020)
    49 Citations
  • Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls

    Vicki S Hertzberg;Harinder Singh;Christina N Fournier;Christina N Fournier;Ahmed Moustafa

    (2021)
    47 Citations
  • Telemedicine is a useful tool to deliver care to patients with Amyotrophic Lateral Sclerosis during COVID-19 pandemic: results from Southern Italy.

    Rosa Capozzo;Stefano Zoccolella;Marco Musio;Roberta Barone

    (2020)
    47 Citations
  • An old friend who has overstayed their welcome: the ALSFRS-R total score as primary endpoint for ALS clinical trials.

    Ruben P A van Eijk;Adriaan D de Jongh;Stavros Nikolakopoulos;Christopher J McDermott

    (2021)
    40 Citations
  • Telehealth as part of specialized ALS care: feasibility and user experiences with "ALS home-monitoring and coaching".

    Jochem Helleman;Remko Van Eenennaam;Esther T. Kruitwagen;Willeke J. Kruithof

    (2020)
    39 Citations

Related Online Degrees & Career Pathways

Exploring alternative and complementary career pathways can enhance your options after studying Medicine in the USA. For those interested in movement science and rehabilitation, pursuing a kinesiology degree online offers a convenient way to deepen your knowledge while balancing clinical practice.

Nurses looking to advance in mental health may consider the shortest post master's PMHNP online programs. These programs provide focused psychiatric mental health training, enabling nurses to become certified with minimal time investment.

Similarly, family nurse practitioners aiming to expand their scope can benefit from the post masters FNP certification. This pathway is designed for those already holding advanced degrees who wish to quickly attain family practice credentials.

For a holistic approach to patient care, online dietetics programs are increasingly popular. Investigating online dietetics programs can lead to careers that focus on nutrition science and wellness, complementing medical practice.

Best Scientists Contributing to This Journal